Clearance in Drug Design
Authors:
Top Cited Papers
- 3 October 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 62 (5) , 2245-2255
Abstract
Due to its implications for both dose level and frequency, clearance rate is one of the most important pharmacokinetic parameters to consider in the design of drug candidates. Clearance can be classified into three general categories, namely metabolic transformation, renal excretion and hepatobiliary excretion. Within each category, there are a host of biochemical and physiological mechanisms that ultimately determine the clearance rate. Physiochemical properties are often indicative of the rate-determining mechanism, with lipophilic molecules tending toward metabolism and hydrophilic, polar molecules tending toward passive or active excretion. Optimization of clearance requires recognition of the major clearance mechanisms and use of the most relevant in vitro and in vivo tools to develop structure-clearance relationships. The reliability of methods to detect and predict human clearance varies across mechanisms. While methods for metabolic and passive renal clearance have proven reasonably robust, there is a clear need for better tools to support the optimization of transporter-mediated clearance.Keywords
This publication has 51 references indexed in Scilit:
- Relevance of Half-Life in Drug DesignJournal of Medicinal Chemistry, 2017
- Volume of Distribution in Drug DesignJournal of Medicinal Chemistry, 2015
- Pharmacokinetics and Metabolism in Drug Design2012
- Drug Metabolism and Pharmacokinetics Quick Guide2011
- Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug DevelopmentThe AAPS Journal, 2009
- Pharmacokinetics and metabolism of a sulphamide NK2antagonist in rat, dog and humanXenobiotica, 2000
- Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearanceJournal of Pharmacokinetics and Biopharmaceutics, 1977
- A physiological approach to hepatic drug clearanceClinical Pharmacology & Therapeutics, 1975
- Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Blood Levels of Drug at the Equilibrium State after Multiple DosingNature, 1965